Open AccessMild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption
Author(s) -
Judit Demeter,
Júlia Weisinger,
Zsolt Nagy
Publication year - 2021
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2021.022
Subject(s) - medicine , myeloid leukemia , tyrosine kinase , covid-19 , leukemia , tyrosine kinase inhibitor , oncology , immunology , virology , cancer , receptor , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom